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Renal synthesis of arglnine in chronic renal failure: In vivo and in ,'itro
studies in rats with 5/6 nephrectomy. Synthesis of arginine (Arg) from
citrulline (Cit) by the kidney is a major source of Arg for the body. The
high level of plasma Cit in chronic renal failure is often thought to result
from the impairment of the renal conversion of Cit to Arg. To verify this
assumption, we performed two studies in Sprague-Dawley rats with 5/6
nephrectomy (CRF rats) and in sham-operated rats (CONT rats). In
study I synthesis of Arg by isolated proximal convoluted tubules (PCT;
the nephron segment exhibiting the highest Arg synthesis) was mea-
sured in vitro with two concentrations of Cit (200 or 50 M) correspond-
ing to those observed in plasma of rats with or without renal failure. In
study lithe net renal uptake of Cit and release of Arg were determined
in vivo by measuring PAH clearance and arterial and renal venous Arg,
and Cit concentrations in anesthetized rats. The in vitro results showed
that Arg synthesis increased only in proportion to the hypertrophy of
remnant PCT (+50%), and was highly and similarly dependent on Cit
concentration in PCT of remnant and normal kidneys (Arg production
with 200 M Cit was 3 times higher than with 50 /MCit for both CONT
and CRF). The in vivo results showed that renal Cit uptake and Arg
release were not altered in CRF: —286 28 versus —326 16 nmol
Cit min' (NS), and + 390 47 versus + 399 22 nmol Arg min'
(NS) in CONT and CRF rats, respectively. This maintenance of a
normal Arg synthesis in CRF in the face of a significant reduction in
renal plasma flow (—30%) and glomerular filtration rate (—60%), prob-
ably results from the cumulative effects of hypertrophy of remnant
PCTs, hyperfiltration in remnant nephrons and high plasma Cit concen-
tration increasing the amount of Cit filtered. Thus, the high plasma level
of Cit in CRF, being a consequence of the progressive decline in
functioning nephrons able to synthetize Arg, also represents a periph-
eral adaptatation that enables a reduced mass of functional tissue to
maintain a constant renal Arg synthesis.
A number of abnormalities in the circulating level of several
amino acids is observed in chronic renal insufficiency. In
end-stage renal failure, some of these alterations result from
malnutrition and can be corrected by appropriate dietary ma-
nipulations. Other alterations appear in the early stage of
chronic renal failure (CRF) and are likely related to the de-
creased metabolic activity of the kidney since this organ is
known to play a major role in the metabolism of several amino
acids [11. An increase in plasma citrulline (Cit) is one of the
earliest and most frequently reported metabolic disorders in
CRF in humans [1—51 and experimental rats and dogs [6—81.
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The amino acid Cit is synthesized exclusively in the intestinal
wall and in the liver [9]. The only metabolic pathway utilizing
Cit as a substrate is that leading to the synthesis of arginine
(Arg). This pathway requires two enzymes, arginino-succinate
synthetase and arginino-succinate lyase, which are found in
significant amounts only in liver and kidney. However, the high
arginase activity present in the liver prevents most of the
liver-borne and of the dietary Arg to reach the peripheral
circulation [10, 11]. On the other hand, intestinal Cit escapes
subsequent metabolism through the liver because of the low
permeability of hepatocytes to this amino acid [9]. In contrast to
the liver, the kidney extracts Cit from the blood and releases
Arg into the circulation in approximately equimolar amounts
[12—14]. It is generally considered that a significant fraction of
the Arg used for muscle protein synthesis originates from the
kidney and derives from intestinal citrulline [15, 16]. Morever,
renal Arg synthesis is necessary for maximal growth in rats [17].
It has recently been shown that Arg is produced almost exclu-
sively in the proximal tubule, with a decreasing intensity from
the early convoluted part to the medullary straight part [18, 19].
The largest fraction of renal Arg synthesis probably occurs at
the expense of filtered Cit [12, 13], reabsorbed in the early part
of the proximal tubule [20].
Apart from its contribution to whole body protein synthesis,
Arg is involved in several metabolic pathways. It is the precur-
sor of creatine and other guanidocompouiids, and of ornithine
and polyamines [21]. It has also recently been shown to be the
precursor of nitric oxide, the endothelium-derived relaxing
factor, involved in the regulation of vascular tone [22]. Thus, in
addition to being a key element of nitrogen metabolism, Arg is
also essential in the cascade of events controlling blood pres-
sure and hemodynamics.
The high level of plasma Cit in CRF is generally thought to
result from the impairment of the renal conversion of Cit to Arg
[2—5]. However, few studies have examined the possible alter-
ations of renal Arg synthesis or of the activity of the enzymes
involved in this synthesis during early or moderate stages of
renal failure. Chan et al studied the activity of the Arg syn-
thetase complex in rats with advanced CRF and found that this
activity, measured on kidney homogenates with non-limiting
concentrations of Cit, was markedly reduced [23]. In patients
with severe chronic renal insufficiency, Tizianello et al have
shown that the renal uptake of Cit and the release of Arg were
reduced by 60 to 70% [14]. However, when factored per unit
glomerular filtration rate (GFR), Cit uptake and Arg release
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were increased threefold compared to those measured in nor-
mal controls [14]. This was not observed for other amino acids.
Finally, Fukuda and Kopple described an increase in Cit level
in peripheral venous plasma in uremic dogs, but the balance
between production and utilization of Cit did not significantly
differ from that in normal animals [8, 24].
The present studies were undertaken to evaluate the renal
uptake of Cit and synthesis of Arg in moderate CRF. Two sets
of experiments were performed in rats with 5/6 nephrectomy
and in sham-operated rats. First, using the microtechnique
recently developed by Levillain et a! [18], we measured Arg
synthesis by microdissected proximal convoluted tubules (PCT)
exposed in vitro to two different concentrations of Cit mimick-
ing plasma concentrations seen in health and in moderate CRF.
Second, we evaluated, in vivo, the net renal uptake of Cit and
release of Arg by measuring renal blood flow and the concen-
trations of Arg and Cit in arterial and in renal venous blood.
Renal blood flow was derived from measurements of PAH
clearance, taking the PAH extraction coefficient into account.
In addition, glomerular filtration rate (GFR; inulin clearance)
was also determined.
Methods
Animals and induction of chronic renal failure
Male Sprague-Dawley rats (Iffa Credo, France) weighing
°200 g were subjected to 5/6 renal ablation (5/6 Nx). Under
anesthesia (Nembutal 6%, 0.1 ml 100g' body wti.p., Abbot,
Ingelheim, Germany) approximatively two-thirds of the left
kidney were infarcted by ligation of two or three branches of the
left renal artery, and the right kidney was removed. Control rats
were sham-operated. Following 5/6 Nx but not sham operation,
rats lose weight for two to three days and recover their initial
body weight about one week later. To prevent a difference in
body weight between the two groups at the time of the final
experiment, rats used as controls were one week younger than
those undergoing 5/6 Nx.
All rats had free access to tap water and standard rat diet
(M25, Extralabo, France), containing 25% protein, until the
time of the acute experiments which took place four to six
weeks after surgery. Each experiment included one sham-
operated rat (CONT) and one rat with 5/6 Nx (CRF).
In vitro study
Arginine synthesis was measured in isolated PCTs. In the
first five experiments, Cit concentration in the medium was set
at a concentration reproducing that seen in rats with CRF (200
/sM). However, the subsequent six experiments included mea-
surements carried in parallel with two different Cit concentra-
tions in the medium (50 and 200 sM).
Isolation of PCT segments. Arg synthesis was studied in PCT
segments isolated from a suspension of cortical tubules ob-
tained by collagenase digestion. Rats were anesthetized with
Nembutal. A blood sample (250 d) was collected from ajugular
vein for subsequent creatinine and urea determinations. An
osmotic diuresis was induced by i.v. administration of 0.7 ml.
100 g body wt of 12% mannitol in 0.45% NaCI, and ureters
were ligated. Three minutes later, kidneys were removed and
weighed. All the following procedures were performed at 0 to
4°C. Kidneys were cut in thin slices along the cortico-medullary
axis using a razor blade. Poles were discarded. Slices were
placed in ice-cold basal medium containing NaCI 137 mrvi,
glucose 5 mrvi, KC1 5 m, lactate 5 mM, MgCl2 1 m, acetate 10
mM, MgSO 0.8 mrs, pyruvate 1 mtvi, Na2HPO4 0.33 mri,
aspartate 0.3 mt, KH2PO4 0.44 mi, glutamine 2 mM, CaCl2 1
m, vitamin mixture 1%, Hepes 20 mtvi, pH 7.4. Under
stereomicroscopic control, the superficial cortex was excised
from each slice with thin scissors. Small cubes ( 1 mm3) were
obtained by forcing the tissue through a piece of stretched
medical gauze with a spatula. They were then submitted to
enzymatic digestion for four to six fifteen-minute periods at
30°C, in basal medium containing 0.03% collagenase (from
Clostridium Histolyticum, CLS II, 172 U/mg; Worthington
Biochemical, Freehold, New Jersey, USA) bubbled with air.
This bubbling ensured a mild agitation of tissue pieces. The
supernatant containing isolated tubules was collected and
poured on a 37 sm opening nylon sieve. The upper face of the
sieve was washed carefully by spreading basal medium with a
syringe (25 g needle) with gentle pressure. Short fragments of
tubules, tubule debris and isolated cells passed through the
sieve while longer segments were retained. The sieve was then
turned over and tubules collected in a glass Petri dish by rinsing
the sieve with incubation medium [basal medium added with
0.1% BSA and 6% Dextran (molecular wt 38,800), final osmo-
lality: 350 mOsm/kg H20)] spread with a syringe. Under ste-
reomicroscopic observation, single pieces of PCT were har-
vested with 0.5 jd incubation medium in a tapered polyethylene
catheter connected to a calibrated Hamilton Microliter syringe
and tranferred onto a siliconized and bovine serum albumin
coated (0.01% BSA, 10 p1 dried) hollow glass slide. Each slide
was covered with another glass slide, sealed with vaseline, and
the tubules were photographed for subsequent morphological
measurements.
Measurement of arginine synthesis. The technique used is
that described by Levillain et a! [18]. It is based on the use of
radiolabeled '4C-Cit, which leads, in presence of the tissue Arg
synthase complex, to the formation of '4C-Arg. This Arg is
continuously degraded by arginase and urease, added in the
incubation medium. End products are NH3 and '4C02. '4C02 is
trapped in KOI-I and measured by liquid scintillation counting.
The amount of '4C02 obtained is stochiometrically equal to that
of Arg formed.
Incubation was started by adding to the 0.5 p1 droplet
containing the tubule, another 0.5 p1 of incubation medium
containing L-(ureido-14C)-Cit (2.1 Gbq . mmol'; New England
Nuclear, Boston, Massachusetts, USA), arginase (from calf
liver, Boehringer, Mannheim, Germany; 83 U mg) and
urease (from jack bean, Boehringer, 100 U mg 1) to produce
final concentrations of 50 or 200 M for Cit (with no cold Cit
added) and of 0.05% and 0.1% for arginase and urease, respec-
tively. The sample was sealed by a cover glass slide containing
a 2 p1 droplet of KOH solution (with the same osmotic pressure
as that of the incubation medium) and immersed for 60 minutes
in a water bath maintained at 37°C. The cover slide was then
removed, and the KOH containing the '4C02 trapped during the
incubation was transferred into a counting vial with 4 ml of
scintillation solution (Pico-Fluor 30, Packard Instruments,
Downers Grove, Illinois, USA).
Calculations and statistics. Length (L) and surface area of
the tubules (S) were measured on micrographs enlarged 200
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times, by using a digitized graphic tablet (Summa Tablet)
connected to a computer. From these parameters, tubular
radius (R) was calculated as S/2L, and the estimated volume of
1 mm length was calculated assuming tubules are cylindrical, as
V ir' r2. 1 mm. The amount of Arg formed was deduced
from the amount of "CO2 counted in the KOH (cpm) according
to the following equation:
[(cpm in sample) — (cpm in blank)]/specific activity of Cit
where the blank is measured in samples without tubules.
Results are expressed in fmoles of Arg produced per mm per
mm tubule length or in pmoles of Arg produced per mm per
mm2 tubule volume.
For each rat and for each Cit concentration, Arg production
was the mean of 7 to 12 samples. Each sample contained 1.5
mm of proximal convoluted tubule. Results are means SEM Of
Arg production measured in 11 experiments (11 CONT and 11
CRF rats) (with 200 M Cit) or six experiments (with 50 rM
Cit). Large variations in absolute values of Arg synthetase
activities were sometimes observed in assays performed on
different days. The statistical significance of the differences
seen between CONT and CRF was thus analyzed by a two way
analysis of variance taking into account the day of the assay (1
to 11) and the group of rat (CONT or CRF). The statistical
significance of the differences related to the different Cit con-
centrations was analyzed by a three way analysis of variance
taking into account the day of the assay (6 to 11), the group of
rats (CONT or CRF) and the Cit concentration (200 or 50 .rM).
In vivo study
This study was performed in eight CRF and eight CONT rats
under mactin anesthesia (Byk-Gulden, Konstanz, Germany; 10
mg 100 g body wt i.p.). Surgery included tracheotomy,
catheterization of the left jugular vein and left femoral artery
(PE 50, Clay Adams, Parsippany, New Jersey, USA), and
ureters (left only in CRF rats) (PE 10). Inulin (750 j.rg
mmnL 100 g body wt'; mutest) and PAH (100 jig' min1
100 g body wt', Nephrotest) were infused i.v. in NaCI 0.9% at
a rate of 10 pi min'' ' 100g body wr' for CONT rats, and in
NaCl0.45%atarateof20jil min' l00gbodywt' forCRF
rats. Mean arterial blood pressure (MAP) was monitored con-
tinuously (Gould, Pressure Processor, Cleveland, Ohio, USA).
After one hour of equilibration, urine was collected for one hour
and 1 ml blood samples were drawn from both the femoral
artery and the left renal vein. For the latter, a 23-gauge needle
connected to a syringe was directly inserted into the renal vein.
Blood was immediately transferred into lithium-heparinized
Vacutainer tubes at 4°C. One-half of each sample was immedi-
ately centrifuged at 3,000 g for five minutes at 4°C and the
plasma recovered. Hematocrit was measured on 150 jil blood
samples. Kidneys were removed and weighed (without dissect-
ing out the necrotic tissue,.
Biochemical measurements. Inulin (anthrone method [25])
and PAH concentrations (Bratton and Marshall's method mod-
ified by Smith et a! [26]) were measured in plasma (arterial and
renal venous for PAH) and urine. Plasma urea and creatinine
concentrations were measured on an Astra 8 Beckman autoan-
alyzer (Beckman Instruments, Fullerton, California, USA).
Citrulline and Arg concentrations were measured in aliquots of
Table 1. Characteristics of rats used for the in vitro and in vivo
studies
P
N CONT CRF (f-test)
In vitro study
Body weight g 11 352 9 342 11 NS
Left kidney weight
absolute mg 11 1661 53 2183 179 <0.05
relative ,ng/100 g body WI 11 459 15 616 40 <0.01
Plasma creatinine iiM 10 45.4 3.6 108.2 7.0 <0.001
Plasma urea mM 8 6.5 0.3 17.4 1.2 <0.001
In vivo study
Body weight g 8 376 7 390 10 NS
Left kidney weight
absolute mg 8 1351 41 1954 178 < 0.001
relative mg/lOO g body WI 8 360 13 498 36 <0.001
Plasma creatinine fiM 8 46.8 1.8 100.1 8.3 <0.001
Plasma urea m 8 6.0 0.4 14.8 0.9 < 0.001
Hematocrit % 8 46.9 0.5 41.6 1.3 <0.001
Systolic blood pressure 8 110.1 4.5 148.8 6.7 < 0.001
mm Hg
The difference in kidney weight between the two studies is due to the
different experimental protocols (see text). N = number of rats (same in
CONT and CRF).
arterial and renal venous whole blood and arterial and renal
venous plasma. Samples were immediately deproteinized with
sulfosalicylic acid 40% (1 .d per 10 jsl aliquot) and centrifuged
for two minutes at 10,000 g after 10 minutes at room tempera-
ture and supernatants stored at —80°C until analysis. Amino
acid analysis was carried out by ion-exchange chromatography
using a Beckman 6300 amino acid analyzer. Before analysis,
samples were half-diluted with buffers (Beckman) containing
two amino acid standards: D-glucosaminic acid and 2-amino-
ethyl cysteine (Sigma Chemical Co., Saint Louis, Missouri,
USA). Plasma from the National Quality Control for Amino
acid Analysis was regularly used to check our method.
Calculations and statistics. Renal plasma flow (RPF) was
calculated from PAH urinary clearance and renal extraction
using the equation of Wolf [27]. Renal blood flow (RBF) was
calculated from RPF and arterial hematocrit. Renal blood cell
flow (RBCF) was calculated as the difference between RBF and
RPF. Amino acid concentration in blood cells was calculated
from amino acid concentration in whole blood and in plasma
and from arterial hematocrit. Net uptake (—) or release (+) of a
given amino acid by the kidney from whole blood was calcu-
lated by multiplying RBF by the veno-arterial difference in
blood concentrations. Similar calculations were made for the
net renal uptake or release from plasma and from blood cells.
Urinary excretion of the two amino acids was not considered in
these calculations since it is known to be negligible [12]. All
results are means SEM. Significant differences between means
were determined by Student's t-test.
Results
In vitro study
Table 1 presents body and kidney weights, and creatinine and
urea plasma concentrations measured on the day of the acute
experiment. The remnant third of the left kidney in CRF rats
became heavier than one kidney of control rats. However, total
renal mass in these rats was only "°66% of that of control rats.




Fig. 1. Radius and volume per unit length of
V'z'A PCi's used for the in vitro measurement of
_________
arginine synthesis in Control and CRF rats (N
= 11 of each). ANOVA, CRF vs. CONT,
CRF <0.001.
A Arg per unit length B
800
Fig. 2. Arginine synthesis in PCT of Control
and CRF rats (N = 11 of each) measured in
the presence of 200 M citrulline. Results are
________ ________ ________ _________
expressed per unit length or per unit volume
of tubule. ANOVA, CRF vs. CONT, *p <
0.03.
Partial nephrectomy resulted in a two- to three- fold increase in
plasma creatinine and urea concentrations.
Morphological measurements of isolated PCT are presented
in Figure 1. PCT of CRF rats were 22%wider and had a 50%
larger volume per unit length than those of control rats. Tubular
radius was 22.6 0.6 and 18.6 0.5 pm (P < 0.001) and tubular
volume per mm tubule length 1.64 0.08 and 1.10 0.06 lO
mm3 (P < 0.001) in CRF and CONT rats, respectively.
Figure 2 shows the rate of Arg synthesis in isolated PCT of
control rats and rats with CRF studied with a Cit concentration
of 200 LM. Arg synthesis per unit length of tubule was about
40% higher in CRF than in CONT rats (587 73 vs. 427 31
fmol min1 mm-', respectively, P < 0.03). This difference
was abolished when results were expressed per unit tubular
volume (384 54 vs. 414 43 pmol min mm3, NS), 0
because the increase in Arg synthesis per mm length was close [Cit] l.tM 50 200
to that of tubular volume per unit length.
Figure 3 displays the influence of Cit concentration on Arg
synthesis in both groups of rats. Results are expressed per unit
tubular volume. Results with 200 M were 3.2 0.3 times
higher than with 50 /LM for CONT rats, and 3.1 0.6 for CRF











































Fig. 3. Influence of citrulline concentration (50 or 200 sM) on arginine
synthesis in PCT of Control and CRF rats (N = 6 of each). Results are
expressed per unit volume of tubule. ANOVA, Cit 50 vs. 200 sM, J' <
0.001.
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rats (NS). The influence of Cit concentration on Arg production
is thus obviously not altered by CRF, at least in the range of
concentration tested. The three way ANOVA shows that the
influence of Cit concentration is highly significant (P < 0.001)
and not different between the two groups.
In vivo study
The remnant kidney of CRF rats in this experimental series
hypertrophied to about the same extent as in the other series,
and was 35% heavier than one kidney of CONT rats (Table 1).
The higher kidney weight found in rats used for the in vitro
experiment may be explained by a greater fluid retention in
nephron and collecting duct lumens due to mannitol diuresis
and ligation of the ureters. Plasma creatinine and urea were
significantly higher and hematocrit significantly lower in CRF
than in CONT rats. Hypertension, characteristic of this model
of CRF, was obvious in the present experiment since mean
arterial pressure one month after surgery was 39 mm Hg higher
in CRF than in CONT rats.
Renal hemodynamic data are presented in Table 2. Whole
kidney GFR (inulin clearance) in CRF was decreased threefold
whereas GFR per g kidney weight was decreased only twofold.
Assuming there are 66,000 nephrons in CONT rats and 11,000 in
5/6 Nx rats, GFR per nephron should be about 47 and 97 nl
min, respectively, that is, a twofold enhancement in CRF,
Comparison of venous and arterial plasma concentrations of
PAH revealed that PAH extraction was markedly diminished in
CRF rats to about 2/3 of that of CONT rats. Renal plasma flow
rate, calculated from PAH clearance and extraction, was 30%
lower in CRF than in CONT, a difference of similar magnitude
as that observed for kidney weight. Consequently, RPF per g
kidney was not altered, but filtration fraction fell in direct
proportion to the fall in GFR. Because of the difference in
hematocrit between the two groups, renal blood flow was
slightly more diminished in CRF than renal plasma flow.
Measurements of arterial and renal venous blood and plasma
amino acid concentrations are shown in Table 3. Plasma Cit
concentration was 2.7-fold higher in CRF than in CONT, while
no difference was found for plasma Arg (Fig. 4). Plasma Cit
concentration was positively and significantly correlated with
plasma creatinine concentration (N = 16 rats, y = 1.64x + 8.94,
r = 0.784, P < 0.01). In CONT as well as in CRF, Cit
concentration in blood cells was similar to that in plasma. In
contrast, Arg concentration in blood cells was threefold higher
than in plasma. In whole blood, negative renal veno-artenal
difference for Cit and positive difference for Arg indicate a net
uptake of Cit and release of Arg by the kidney. Renal blood and
plasma (Fig. 4) Cit uptake as well as Arg release were compa-
rable in CRF and CONT groups. In both conditions, plasma and
blood cells contributed unequally to the movements of each
amino acid. Blood cells, during their transit through the kidney,
provided about 15% of the Cit extracted, but did not take up any
of the newly formed Arg. All the Arg released by the kidney(s)
remained in plasma and enhanced plasma concentration in the
renal vein by 27% in CONT and by 40% in CRF rats.
Discussion
The present studies were carried out to evaluate the capacity
of the kidney to extract Cit and synthesize Arg when renal
function is partially impaired. In vivo and in vitro approaches






absolute mi/mm 3.08 0,26 1.07 0.11 <0.001
relative mi/mm g kidney 1.14 0.09 0.56 0.05 < 0.001
PAH extraction % 90.8 2.1 58.3 7.0 <0.001
Renal plasma flow
absolute ml/,nin 9.66 0.93 6.64 0.45 < 0.001
relative mi/mm g kidney 3.57 0.33 3.65 0.48 NS
Renal blood flow
absolute mi/mm 17.09 1.84 10.43 0.57 < 0.001
relative pn!/rnin g kidney 6.31 0.64 5.66 0.62 NS
Filtration fraction % 32.3 1.7 16.9 2.0 < 0.001
These results concern two kidneys in CONT rats and left remnant
kidney in CRF rats.
were used in two separate experiments, each of which was
performed in parallel in 5/6 nephrectomized and in sham-
operated rats. At the time of the study, rats of both series had
reached a comparable and moderate level of renal insufficiency
since, in both series, plasma creatinine and plasma urea con-
centrations were about 2.5 to 3 times higher than in control rats.
Renal hypertrophy and hemodynamics
Whole kidney and PCT hypertrophy. Relative left kidney
mass was 34 and 38% higher in CRF than in CONT rats, in the
in vitro and in vivo studies, respectively. The degree of kidney
hypertrophy following renal ablation was thus very similar in
both series. The absolute hypertrophy of functional tissue may
be less than suggested by the absolute kidney weights because
of the presence of necrotic tissue corresponding to infarcted
regions.
PCT volume per unit length was =50% greater in CRF than in
CONT rats. Most probably, cellular hypertrophy also resulted
in an increase in length of PCT per nephron. Although PCT
length was not evaluated, the increase in PCT length in CRF
versus control rats can be estimated if one assumes that, after
5/6 renal ablation, glomerulo-tubular balance was maintained by
parallel increments in GFR and in PCT volume, as was reported
for nephritic kidneys [reviewed in 281. In the present experi-
ments, total PCT volume per nephron should have doubled to
match the calculated increase in single nephron GFR (97 vs. 47
nl min, that is, 206% of control, see Results). Since PCT
volume per unit length in CRF was 149% of that in control rats,
a 38% increase in PCT length (= 206/149) has probably taken
place in CRF rats.
Renal hemodynamics. CRF rats had a much lower GFR and
RPF than CONT rats. However, the difference between the two
groups was greater for GFR than for RPF, revealing a marked
and significant decline in filtration fraction in CRF. Such a
decline has rarely been reported in the remnant kidney model.
In the study of Zoja et al [29] in Sprague-Dawley rats, 45 days
after 5/6 renal ablation, the clearance of inulin was comparable
but that of PAH was lower than the value found in the present
study. In contrast, Yoshida, Fogo and Ichikawa [30] found a
greater decline in single nephron filtration fraction in rats with
5/6 nephrectomy than in rats with 1/3 nephrectomy (0.22 vs.
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Tabe 3. Citrulline and arginine concentrations and renal fluxes in the in vivo study
Citrulline Arginine
CONT CRF P CONT CRF P
N = 8 N = 8 (t-test) N = 8 N = 8 (t-test)
Whole blood
Arterial concentration jii 71 2 191 15 < 0.001 275 16 275 15 NS
Venous concentration pM 52 3 155 14 < 0.001 289 15 315 20 NS
RV-A difference i —19.2 1.1 —36.6 3.1 <0.001 23.8 1.9 40.5 5.2 <0.01
Rate nmol/min —339 30 —371 22 NS 384 61 408 39 NS
Plasma
Arterial concentration jtM 70 1 190 13 < 0.001 154 9 156 12 NS
Venous concentration /J.M 42 I 138 11 < 0.001 195 9 218 17 NS
RV-A difference pM —28.9 0.7 —51.5 5.4 <0.001 41.0 3.9 62.5 6.0 <0.001
Rate nmol/min —286 28 —326 16 NS 390 47 399 22 NS
Blood cells
Arterial concentration p 71 4 196 21 <0.001 431 21 485 21 <0.01
Venous concentration jtM 63 5 185 21 < 0.001 422 21 486 25 < 0.02
RV-A difference !.LM —7.6 2.2 —11.7 5.5 NS 4.9 5.6 0.9 8.7a
Rate nmol/min —51 11 —46 17 NS
Abbreviation is RV-A, renal venous minus arterial concentration.


















Comparison of in vitro and in vivo conditions. The rate of
arginine synthesis found in control rats in this study is in the
same order of magnitude as that previously reported in vitro
[12, 18] and in vivo [12]. The results of the present studies,
however, suggest that the rate of Arg synthesis observed in
vitro is somewhat lower than that occurring in vivo. Assuming
two rat kidneys contain 66,000 nephrons with 10 mm long
PCTs, total renal release of Arg estimated from in vitro mea-
surements in normal rats with 50 tM Cit in the medium would
be 108 nmol min', that is, about threefold less than observed
in the in vivo study. This difference most probably results from
the different modes of Cit delivery to PCT cells in the two
conditions as already discussed by Levillain et al [18]. In vivo,
a continuous transcellular flow of Cit takes place in the early
proximal PCT because of the reabsorption of filtered amino
acids, thus providing ample substrate supply for the activity of
the Arg synthase complex, whereas in vitro, in the absence of
fluid movement in the lumen, luminal entry of Cit is probably
low, and the rate of Arg synthesis is probably limited by the rate
of the basolateral uptake of Cit [32].
Renal Cit uptake and Arg release in CRF. Present results
confirm the fact that blood and plasma Arg levels are main-
tained within a normal range in CRF, as already reported by
others [3, 6—8, 14, 24]. However, this study does not support the
usually accepted concept of a diminished capacity of the
diseased kidney to synthesize Arg. The renal uptake of Cit and
release of Arg proceeded at a normal rate in the experimental
rats despite the reduced renal mass and impaired renal hemo-
dynamics. The findings of the in vitro study suggest that this
adaptation results from the combination of three factors, hyper-
trophy, increased substrate concentration, and hyperfiltration,
as explained below.
Arg synthesis per unit PCT volume is not increased in rats
with CRF. Thus, the increase in Arg synthesis per remnant
nephron will be increased only in proportion to PCT hypertro-
phy. Combining the hypertrophy in volume per unit length






Fig. 4. Plasma concentration (A) and net rena/flux (B) of citrulline and
arginine in Control and CRF rats (N = 8 of each). Student's t-test,
CONT vs. CRF, *p < 0.001.
0.28), and Allison, Wilson and Gottschalk, in rats with experi-
mental nephritis, observed that the rise in RPF exceeded that in
GFR, resulting in a fall in filtration fraction (14 vs. 27% in
controls) [311. These discrepancies remain unexplained.
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synthetic capacity per nephron can be expected. This alone will
obviously not compensate for the massive reduction in nephron
number. On the other hand, it has been established both in vivo
and in vitro that renal synthesis of Arg is limited primarily by
the availability of Cit rather than by the activity of the two
enzymes involved in this synthesis [12, 18], contrary to what
occurs in the liver [16]. The dependency of renal Arg synthesis
on substrate concentration is unaffected by extensive renal
ablation and PCI hypertrophy (Fig. 3). In vitro, a fourfold
increase in Cit concentration increased Arg synthesis by iso-
lated PCTs about threefold, in CRF as in CONT rats. In vivo, an
increase in circulating Cit concentration will enable renal Arg
synthesis to proceed at a higher rate by two additive effects: (1)
by providing a higher substrate concentration around PCT cells,
and (2) by increasing the amount of Cit ifitered (in addition to
the increase already due to nephron hyperfiltration). Higher
amino acid filtration is known to increase the length of proximal
tubule concerned with their reabsorption [321. Thus the marked
elevation in filtered Cit probably increases the length of PCT
involved in Cit reabsorption-dependent Arg synthesis.
At variance with our results, Chan et al [231 described a
significantly reduced capacity for Arg synthesis in chronic renal
failure. Very different experimental conditions in the two stud-
ies may account for this discrepancy. Chan et al's report
concerned rats with severe renal failure and their study protocol
was designed to minimize hypertrophy of the remnant kidney.
The measurements were performed on kidney homogenates in
the presence of a very high Cit concentration (7.5 mM) leading
enzymatic activity to reach its maximal velocity, a condition
never met in the kidney in vivo [121. In the present study, CRF
was less advanced, tubules with intact living cells were studied,
and the range of Cit concentration used was much lower and
comparable to that found in vivo.
However, a few observations suggest that, in some patholog-
ical situations, Arg from dietary or hepatic origin may obviously
become available in greater proportion for body needs. Indeed,
patients with terminal renal failure and nephrotic patients
exhibit Arg plasma levels within the normal range in spite of a
complete lack of renal synthesis. On the other hand, the
relatively low Arg plasma levels seen in children with a genetic
argininosuccinate synthetase deficiency are not corrected by
liver transplantation [33]. This reveals the importance of the
kidney in providing Arg during growth in humans as had been
shown by another approach in rats [17].
Plasma/red cell balance, and Cit/Arg balance. In both CRF
and healthy rats, addition of Arg to renal venous blood was
mostly accounted for by changes in plasma rather than in blood
cell Arg concentration. This observation is in agreement with
that of Dhanakoti et al [12] in the normal rat. In contrast, in
healthy humans, Tizianello et al [14] reported a role for blood
cells in Arg exchange accross the kidney. Another difference
between rats and humans concerns the plasma-erythrocyte
difference for Arg concentration. In humans, Arg concentration
is two- to threefold higher in plasma than in erythrocytes [34,
35], whereas in rats, Arg level is higher in blood cells than in
plasma (by 2.7-fold in our study).
In most rat [9, 12] and human studies [141, it is generally
stated that renal Arg release is equimolar to renal Cit uptake.
We found a significant correlation between the two parameters
(r 0.654, P 0.006) but Arg release exceeded Cit uptake by
about 10% in both groups of rats. This positive difference could
correspond to Arg liberated from small filtered peptides, reab-
sorbed and hydrolyzed by the proximal tubule, since the kidney
is known to extract and catabolize about 30% of plasma
proteins with molecular weight below 10,000 daltons [36].
Elevation of plasma citrulline in CRF
The elevation of plasma Cit in CRF (a threefold increase in
the present study) is generally assumed to be a consequence of
impaired renal Arg synthesis. At first glance, this may appear
untrue since renal Arg synthesis was found to be normal in the
present study. However, as explained above, the hypertrophy
of remaining nephrons does not compensate, by far, for the
reduction in nephron number. This relative impairment leads
Cit to accumulate in plasma until plasma Cit concentration
enables renal production of Arg to match the unchanged intes-
tinal Cit production. Thus, because of the dependency of Arg
synthesis on substrate concentration, the elevated level of Cit
seen in CRF represents a peripheral adaptation that enables a
progressively declining mass of functional tissue to maintain a
constant renal synthesis. This adaptation is similar to that of
GFR and creatinine excretion. Progressive hyperfiltration of
remaining nephrons does not restore a normal whole kidney
GFR. As a consequence, plasma creatinine increases to a level
that enables the daily excretion of creatinine to match the daily
production, in the face of a reduced filtration rate. This simi-
larity is corroborated by the significant correlation observed
between plasma Cit and plasma creatinine concentrations in
rats (present report) and in patients with different degree of
renal failure [3]. It is also interesting to note that the increase in
plasma Cit seen in CRF rats in the present study is just appropri-
ate to maintain Cit filtration at the same level as in normal rats.
Plasma Cit times GFR (Tables 2 and 3) is indeed similar in the two
conditions (216 and 203 nmollmin, respectively).
In summary, present experiments show that total renal Arg
synthesis is not diminished in the remnant kidney model of
CRF, in contrast with a significant reduction in GFR. The
maintenance of a normal Arg synthesis probably results from
the combination of three factors: (1) hypertrophy of proximal
tubule in remnant nephrons which approximately doubles Arg
synthetic capacity per nephron; (2) hyperfiltration which in-
creases the amount of Cit filtered per nephron and lengthens the
portion of their proximal tubule involved in Cit reabsorption
and Arg synthesis; (3) increase in plasma Cit concentration
which enhances Arg synthesis because of the concentration-
dependency of this synthesis in the kidney.
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